Use of Impedance Cardiography to Decrease the Risk of Pre-eclampsia in Obese Patients

• Status: Unknown status
• Trial end date: 2020-03-04
• Target enrollment: 0
• Participant gender: Female

Summary

To determine if the use of impedance cardiography can identify appropriate medications for use in treating morbidly obese patients to decrease the risk of preeclampsia.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Tennessee Graduate School of Medicine
• Treatments: Atenolol; Labetalol; Nifedipine

Criteria

Inclusion Criteria:

• Pregnant patients 18-51 years old,

• Less than 20 weeks gestation with Morbid Obesity (BMI >/= 40)

• Not on antihypertensive medications

Exclusion Criteria:

• Patients with an allergy to antihypertensive medication or contraindication for their usage such as certain cardiac or neurologic disorder during pregnancy

• Patients who have a blood pressure 140/90 or greater